The potential utility of cord blood DNA methylation in pediatric clinical practice
Epigenomics · 2024
DOI: 10.1080/17501911.2024.2408217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epigenomics, 2024. Verfasst von Stephanie W Waldrop und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section on Nutrition, Department of Pediatrics, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: DNA Methylation, Epigenesis, Genetic, Fetal Blood. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Our understanding of the origins of noncommunicable diseases has evolved over the years with greater consideration given to the lasting influence exposures and experiences during the preconceptional and prenatal periods can have. Research highlights the associations of parental exposures (e.g., diet, obesity, gestational diabetes, lipid profile, toxic exposures and microbiome) with the infant/fetal methylome and suggest associations with infant, child and/or adolescent chronic health outcomes. Thus, epigenetics and specifically cord blood DNA methylation may have utility as biomarkers for disease risk identification and stratification in pediatrics. However, for cord blood DNA methylation analyses to be leveraged as biomarkers of disease risk in pediatric clinical practice, the results must be replicable, validated and clinically meaningful. Challenges and opportunities to this prospect are herein discussed. [Box: see text].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section on Nutrition, Department of Pediatrics, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.
- Division of Clinical Sciences, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 70808, USA.
- Lifecourse Epidemiology of Adiposity & Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Department of Pediatrics, TSET Health Promotion Research Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
ORCID-Profile: Stephanie W Waldrop
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Waldrop, S. W., Perng, W., Konigsberg, I. R., & Borengasser, S. J. (2024). The potential utility of cord blood DNA methylation in pediatric clinical practice. Epigenomics. https://doi.org/10.1080/17501911.2024.2408217
Vancouver
Waldrop SW, Perng W, Konigsberg IR, Borengasser SJ. The potential utility of cord blood DNA methylation in pediatric clinical practice. Epigenomics. 2024. doi:10.1080/17501911.2024.2408217
BibTeX
@article{Waldrop2024,
author = {Waldrop, Stephanie W and Perng, Wei and Konigsberg, Iain R and Borengasser, Sarah J},
title = {The potential utility of cord blood DNA methylation in pediatric clinical practice},
journal = {Epigenomics},
year = {2024},
doi = {10.1080/17501911.2024.2408217}
}
EUVIMED